Jacobs Levy Equity Management, Inc Pliant Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

  • $23.9 Billion
  • Q3 2025

A detailed history of Jacobs Levy Equity Management, Inc transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 367,113 shares of PLRX stock, worth $635,105. This represents 0.0% of its overall portfolio holdings.

Number of Shares
367,113
Holding current value
$635,105
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 17, 2025
BUY
$1.18 - $1.86 $433,193 - $682,830
367,113 New
367,113 $543,000
Q1 2022

May 16, 2022
SELL
$7.01 - $14.1 $101,946 - $205,056
-14,543 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$12.27 - $18.26 $178,442 - $265,555
14,543 New
14,543 $196,000

About PLIANT THERAPEUTICS, INC.

PLRX Quotes by TradingView
  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $84.2M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email